Brca1-deficient murine mammary epithelial cells have increased sensitivity to CDDP and MMS

被引:47
|
作者
Sgagias, MK
Wagner, KU
Hamik, B
Stoeger, S
Spieker, R
Huber, LJ
Chodosh, LA
Cowan, KH
机构
[1] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA
[2] Univ Penn, Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA
[4] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA
关键词
Bcra1-deficiency; DNA-damage and repair; breast cancer; CDDP; MMS;
D O I
10.4161/cc.3.11.1211
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In this report we describe the isolation of an isogenic pair of Brca1(++) and Brca1(-/-) murine mammary epithelial cells (MMECs). These cells were isolated from Brca1 conditional knock-out mice which contained loxP sites flanking exon 11 of the Brca1 gene (Brca1(f1/f1)) and then immortalized by infection with HPV-16E6 retrovirus to degrade p53 protein. Brca1-/- MMECs were generated by deletion of exon 11 following transduction of Brca1(f1/f1) MMECs with a retroviral vector expressing Cre recombinase. Brca1-deficiency rendered MMECs sensitive to cis-platinum (II) diamine dichloride ( CDDP) and methylmethane sulfonate (MMS). The Brca1(+/+) and Brca1(-/-) MMECs is the only known pair of isogenic mammary epithelial cell lines. The understanding of the mechanisms of the CDDP sensitivity of the BRCA1-deficient mammary epithelial cells would be very important in understanding how BRCA1-deficiency plays a role in tissue specific breast cancer chemotherapy. These studies support the role of BRCA1 in the CDDP-induced and MMS-induced DNA damage and repair by p53-independent pathways.
引用
收藏
页码:1451 / 1456
页数:6
相关论文
共 50 条
  • [1] PDGFRβ is an essential therapeutic target for BRCA1-deficient mammary tumors
    Feng Bai
    Shiqin Liu
    Xiong Liu
    Daniel P. Hollern
    Alexandria Scott
    Chuying Wang
    Lihan Zhang
    Cheng Fan
    Li Fu
    Charles M. Perou
    Wei-Guo Zhu
    Xin-Hai Pei
    Breast Cancer Research, 23
  • [2] PDGFRβ is an essential therapeutic target for BRCA1-deficient mammary tumors
    Bai, Feng
    Liu, Shiqin
    Liu, Xiong
    Hollern, Daniel P.
    Scott, Alexandria
    Wang, Chuying
    Zhang, Lihan
    Fan, Cheng
    Fu, Li
    Perou, Charles M.
    Zhu, Wei-Guo
    Pei, Xin-Hai
    BREAST CANCER RESEARCH, 2021, 23 (01)
  • [3] p16 loss rescues functional decline of Brca1-deficient mammary stem cells
    Scott, Alexandria
    Bai, Feng
    Chan, Ho Lam
    Liu, Shiqin
    Slingerland, Joyce M.
    Robbins, David J.
    Capobianco, Anthony J.
    Pei, Xin-Hai
    CELL CYCLE, 2017, 16 (08) : 759 - 764
  • [4] Mammary tumor formation in p53- and BRCA1-deficient mice
    Cressman, VL
    Backlund, DC
    Hicks, EM
    Gowen, LC
    Godfrey, V
    Koller, BH
    CELL GROWTH & DIFFERENTIATION, 1999, 10 (01): : 1 - 10
  • [5] p16INK4a suppresses BRCA1-deficient mammary tumorigenesis
    Scott, Alexandria
    Bai, Feng
    Chan, Ho Lam
    Liu, Shiqin
    Ma, Jinshan
    Slingerland, Joyce M.
    Robbins, David J.
    Capobianco, Anthony J.
    Pei, Xin-Hai
    ONCOTARGET, 2016, 7 (51): : 84496 - 84507
  • [6] Impact of Intertumoral Heterogeneity on Predicting Chemotherapy Response of BRCA1-Deficient Mammary Tumors
    Rottenberg, Sven
    Vollebergh, Marieke A.
    de Hoon, Bas
    de Ronde, Jorma
    Schouten, Philip C.
    Kersbergen, Ariena
    Zander, Serge A. L.
    Pajic, Marina
    Jaspers, Janneke E.
    Jonkers, Martijn
    Loden, Martin
    Sol, Wendy
    van der Burg, Eline
    Wesseling, Jelle
    Gillet, Jean-Pierre
    Gottesman, Michael M.
    Gribnau, Joost
    Wessels, Lodewyk
    Linn, Sabine C.
    Jonkers, Jos
    Borst, Piet
    CANCER RESEARCH, 2012, 72 (09) : 2350 - 2361
  • [7] Sox11 regulates mammary tumour-initiating and metastatic capacity in Brca1-deficient mouse mammary tumour cells
    Tsang, Siu Man
    Kim, Hyojin
    Oliemuller, Erik
    Newman, Richard
    Boateng, Naa-Anyima
    Guppy, Naomi
    Howard, Beatrice A.
    DISEASE MODELS & MECHANISMS, 2021, 14 (05)
  • [8] Cell cycle checkpoints in BRCA1-deficient embryonic stem cells
    Snouwaert, JN
    Pace, AJ
    Gowen, LC
    Xiao, A
    Nichols, MA
    Xiong, Y
    Koller, BH
    FASEB JOURNAL, 1999, 13 (07): : A1538 - A1538
  • [9] High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs
    Rottenberg, Sven
    Jaspers, Janneke E.
    Kersbergen, Ariena
    van der Burg, Eline
    Nygren, Anders O. H.
    Zander, Serge A. L.
    Derksen, Patrick W. B.
    de Bruin, Michiel
    Zevenhoven, John
    Lau, Alan
    Boulter, Robert
    Cranston, Aaron
    O'Connor, Mark J.
    Martin, Niall M. B.
    Borst, Piet
    Jonkers, Jos
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (44) : 17079 - 17084
  • [10] Chemopreventive Effects of ROS Targeting in a Murine Model of BRCA1-Deficient Breast Cancer
    Li, Mo
    Chen, Qian
    Yu, Xiaochun
    CANCER RESEARCH, 2017, 77 (02) : 448 - 458